Tag: prnewswire

TSY-110 is positioned to become the first biosimilar alternative to Roche's Kadcyla® (ado-trastuzumab emtansine) in major regulated markets. TAIPEI, Aug. ...

Asieris Pharmaceuticals Releases 2026 Semi-Annual Report: Core Product Commercialization Delivers, Entering a Harvest Period as the Company Accelerates Its Transition to Biopharma

SHANGHAI, Aug. 28, 2026 /PRNewswire/ -- Asieris Pharmaceuticals today released its 2026 Semi-Annual Report, showing comprehensive progress across all business ...

Kazia Therapeutics Limited Announces Pricing of Up to $120 Million Public Offering

SYDNEY, Aug. 28, 2026 /PRNewswire/ -- Kazia Therapeutics Limited (NASDAQ: KZIA) ("Kazia" or the "Company"), an oncology-focused biotechnology company developing therapies ...

InxMed Announces Publication in The Lancet Oncology Featuring Encouraging Antitumor Activity of Ifebemtinib in Combination with Garsorasib in Previously Treated Metastatic Colorectal Cancer (CRC) Harboring KRAS G12C Mutation

NANJING, China, Aug. 28, 2026 /PRNewswire/ -- InxMed Co., Ltd ("InxMed"), a clinical-stage biotechnology company dedicated to developing innovative therapies ...

Dell Technologies: From Technical Debt to Agility – Why CIOs Are Rethinking Private Cloud

SINGAPORE, Aug. 28, 2026 /PRNewswire/ -- Chris Kelly, Senior Vice President of Data Center Solutions, Asia Pacific, Japan and Greater ...

Kunlun Capital-Backed InfiMaker Surpasses US$4 Million in Kickstarter Pledges, Following US$1.5 Million First‑Day Debut

BEIJING, Aug. 28, 2026 /PRNewswire/ -- InfiMaker, which received an exclusive lead investment from Kunlun Capital in its angel round ...

Tigermed Announces 2026 Interim Results

HANGZHOU, China, Aug. 28, 2026 /PRNewswire/ -- Hangzhou Tigermed Consulting Co., Ltd. (300347.SZ / 3347.HK), a leading global provider of ...

Warpify Robotics Secures Pre-Series A Funding for Global Expansion